VHL and von Hippel-Lindau disease: For individuals with an apparently sporadic haemangioblastoma and a negative VHL genetic test, the risk of cryptic VHL disease is significantly diminished; however, the sensitivity of VHL gene testing is ~95%, and false negative tests may occur through mosaicism or the location of pathogenic variants in intronic regions [14,15,16].